Haw Par is a strong consumer healthcare business promoting healthy lifestyles through its healthcare products. Beyond healthcare, the company engages in long-term securities investing, property leasing, and leisure activities including oceanariums.
Cyborg Score Rationale
The company maintains excellent financial strength with a current ratio of 6.21 and minimal debt (0.01 debt-to-equity). Stock price has increased 31.79% over the past 52 weeks, reflecting positive market sentiment toward the diversified portfolio.
Top Insights
Tiger Balm brand operates in 100+ countries as a leading topical analgesic with global recognition and distribution reach
Strong financial position: SGD 699.51M cash, minimal debt, and 2.34% dividend yield with disciplined capital allocation
Diversified business model reduces consumer healthcare exposure risk through investments, property, and leisure segments
Stock classified as "High Flyer" with 31-56% appreciation over past year, indicating strong investor confidence
Named Competitors
Pain Relief Products — Global OTC pain management solutions
Regional Topical Analgesics — Regional competitors in topical pain relief
Recent Developments
(Feb 2026) Stock traded near all-time high of 17.25 SGD with continued positive momentum
(Dec 2025) Earnings showed strong performance with SGD 144.14M net income in latest half-year
(2025) Dividend yield maintained at competitive 2.34% with consistent shareholder returns
Open the full interactive Haw Par Corporation Limited report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.